OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 278 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$229,000
-100.0%
10,000
+15.4%
0.01%
-50.0%
Q1 2018$642,000,0008,6650.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Evolutionary Tree Capital Management, LLC 68,937$5,138,0003.04%
Avoro Capital Advisors LLC 2,150,000$160,240,0002.77%
Casdin Capital, LLC 550,000$40,992,0001.22%
TOBAM 371,107$27,659,0001.18%
Ikarian Capital, LLC 455,900$33,978,0001.14%
Eventide Asset Management 697,156$51,959,0000.77%
FOX RUN MANAGEMENT, L.L.C. 4,902$365,0000.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 31,500$2,348,0000.62%
Sivik Global Healthcare LLC 20,000$1,491,0000.54%
Rock Springs Capital Management LP 328,750$24,502,0000.54%
View complete list of SAREPTA THERAPEUTICS INC shareholders